We evaluated the ability of new thyrotropin (TSH) assays to separate hyperthyroid (n = 50) patients from clinically euthyroid subjects with low TSH values (nodular goiter, n = 20, and nonthyroidal illness, n = 22). Only patients whose serum TSH was <0.1 mlU/L by immunoradiometnc assay were included. We used a new immunofluoromettic method based on time-resolved fluorescence (TA-IFMA) and a new immunochemiluminometric assay (ICMA) to measure TSH in serum. Afthough the differences between the hyperthyroid patients and the euthyroid patients differed from each other by both methods (P = 0.0012 for TR-IFMA and P <0.0001 for ICMA), there was no cutoff point that could definitely separate the groups. Thus, it is not possible to draw any definite conclusionson whether a patient is hyperthyroidor not, solely on the basis of TSH concentration measured with these new TSH assays. 
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9-13).
We studied the ability of a time-resolved inununofluorometric assay (TR-IFMA) and an immunochemilununometric assay (ICMA) for TSH in serum to separate euthyroid individuals with low serum thyrotropin (<0.1 mJlJ/L) from hyperthyroid patients. We also studied the extent of agreement between these methods. Theprofiles were calculated from means of 10 to 40 duplicate measurements of serum samples.
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136 . We also measured 41 serum samples between TSH concentrations of 0.01 and 0.1 mIU/L (Fig. 3) 
TSH Measurementsin Serum from Hyper-and EuthyroidSubjects
The distribution of serum TSH concentrations in the three groups of patients displayed the bias between the TSH results of the two TSH methods (Figs. 4 and 5) . The descriptions of the distributions for TSH are presented in Table 1 . Analysis of variance revealed significant differences between results for the three study groups by both TR-WMA and ICMA (P = 0.0012 and P <00001, respectively).
For both methods, significant differences were found between hyperthyroid patients and patients with goiter, and between hyperthyroid and NT! The optimal diagnostic efficacy, based on the assumption that sensitivity and specificity were equally important, was achieved at cutoff points of 0.018-0.020 and 0.0 11 mIU/L for TR-!FMA and !CMA, respectively. This study was financially supported by Turku University Foundation.
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